Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors

NEXT STORY
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in the U.S. Phase 1 Clinical Trial of the CD73 Antibody TJD5 in Patients with Advanced Solid Tumors
PREV STORY
Iterum Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

The Global Gene Therapy Market is forecast to hit $363 million by 2022

NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- A new study “Global Gene Therapy ...

author_avatar
NASDAQ Market News

PetLife Pharmaceuticals Announces Investor Analysts Research Report

Hancock, MD, Aug. 23, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the ...

author_avatar
NASDAQ Market News

Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey

author_avatar
NASDAQ Market News